Controlled size chitosan nanoparticles as an efficient, biocompatible oligonucleotides delivery system

Journal of Applied Polymer Science

Volumn 118, Issue 4, 2010, Pages 2071-2077

  Manchanda, Romila ^a   Nimesh, Surendra ^b  

^a Florida International University   (United States)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Biodegradable; Crosslinking; Nanoparticle; Particle size distribution

Indexed keywords

ACIDIC MEDIUMS; AQUEOUS BUFFER; BIODEGRADABLE; CELL VIABILITY; CHITOSAN NANOPARTICLES; CONTROLLED SIZE; CROSSLINKED; DELIVERY SYSTEMS; DYNAMIC LASER SCATTERING; GLUTARALDEHYDES; HEK293 CELLS; IN-VITRO; LIPOFECTAMINE; LYOPHILIZED POWDERS; NARROW SIZE DISTRIBUTIONS; OPTICALLY CLEAR; PH-DEPENDENT; POLYMERIC NANOPARTICLES; REVERSE MICELLAR SYSTEM; SMOOTH SURFACE; SPHERICAL PARTICLE; TEM; TEM IMAGES;

ALDEHYDES; CHITIN; CHITOSAN; CROSSLINKING; DYNAMIC LIGHT SCATTERING; MORPHOLOGY; OLIGONUCLEOTIDES; PARTICLE SIZE ANALYSIS; SIZE DISTRIBUTION; TRANSMISSION ELECTRON MICROSCOPY;

NANOPARTICLES;

EID: 77956443014     PISSN: 00218995     EISSN: 10974628     Source Type: Journal    
DOI: 10.1002/app.32508     Document Type: Article

References (25)

1. Lebedeva, I.; Stein, C. A. Annu Rev Pharmacol Toxicol 2001, 41, 403.
2. Harada, A.; Togawa, H.; Kataoka, K. Eur J Pharm Sci 2001, 13, 35.
3. Levin, A. A. Biochim Biophys Acta 1999, 1489, 69.
4. Galbraith, W. M.; Hobson, W. C.; Giclas, P. C.; Schechter, P. J.; Agrawal, S. Antisense Res Dev 1994, 4, 201.
5. Dagle, J. M.; Andracki, M. E.; Devine, R. J.; Walder, J. A. Nucl Acids Res 1991, 19, 1805.
6. Hanvey, J. C.; Peffer, N. J.; Bisi, J. E.; Thomson, S. A.; Cadilla, R.; Josey, J. A.; Ricca, D. J.; Hassman, C. F.; Bonham, M. A.; Au, K. G.; Carter, S. G.; Bruckenstein, D. A.; Boyd, A. L.; Noble, S. A.; Babiss, L. E. Science 1992, 258, 1481.
7. Hughes, M. D.; Hussain, M.; Nawaz, Q.; Sayyed, P.; Akhtar, S. Drug discovery Today 2001, 6, 303.
8. Fattal, E.; Vauthier, C.; Aynie, I.; Nakada, Y.; Lambert, G.; Malvy, C.; Couvreur, P. J Control Release 1998, 53, 137.
9. Chavany, C.; Ledoan, T.; Couvreur, P.; Puisieux, F.; Helene, C. Pharm Res 1992, 9, 441.
10. Zobel, H. P.; Kreuter, J.; Werner, D.; Noe, C. R.; Kumel, G.; Zimmer, A. Antisense Nucleic Acid Drug Dev 1997, 7, 483.
11. He, X. X.; Wang, K. M.; Tan, W. H.; Liu, B.; Lin, X.; He, C. M.; Li, D.; Huang, S. S.; Li, J. J Am Chem Soc 2003, 125, 7168.
12. He, X. X.; Wang, K. M.; Tan, W. H.; Liu, B.; Lin, X.; Huang, S. S.; Li, D.; He, C. M.; Li, J. Chin Sci Bull 2003, 48, 223.
13. Aspden, T. J.; Mason, J. D. T.; Jones, N. S.; Lowe, J.; Skaugrud, O.; Illum, L. J Pharm Sci 1997, 86, 509.
14. Mao, H. Q.; Roy, K.; Troung-Le, V. L.; Janes, K. A.; Lin, K. Y.; Wang, Y.; August, J. T.; Leong, K. W. J Control Release 2001, 70, 399.
15. Illum, L. Pharm Res 1998, 15, 1326.
16. Xu, Y.; Du, Y. Int J Pharm 2003, 250, 215.
17. Koping-Hoggard, M.; Varum, K. M.; Issa, M.; Danielsen, S.; Christensen, B. E.; Stokke, B. T.; Artursson, P. Gene Ther 2004, 11, 1441.
18. Kim, T. H.; Kim, S. I.; Akaike, T.; Cho, C. S. J Control Release 2005, 105, 354.
19. Mansouri, S.; Cuie, Y.; Winnik, F.; Shi, Q.; Lavigne, P.; Benderdour, M.; Beaumont, E.; Fernandes, J. C. Biomaterials 2006, 27, 2060.
20. Banerjee, T.; Mitra, S.; Singh, A. K.; Sharma, R. K.; Maitra, A. Int J Pharm 2002, 243, 93.
21. Mosmann, T. J Immunol Methods 1983, 65, 55.
22. Prabha, S.; Zhou, W. Z.; Panyam, J.; Labhasetwar, V. Int J Pharm 2002, 244, 105.
23. Anthonsen, M. W.; Smidsrod, O. Carbohydr Polym 1995, 26, 303.
24. Carreno-Gomez, B.; Duncan, R. Int J Pharm 1997, 148, 231.
25. Richardson, S. C.; Kolbe, H. V.; Duncan, R. Int J Pharm 1999, 178, 231.